Pérez-Belmonte, L.M.; Ricci, M.; Sanz-Cánovas, J.; Cobos-Palacios, L.; López-Carmona, M.D.; Ruiz-Moreno, M.I.; Millán-Gómez, M.; Bernal-López, M.R.; Jansen-Chaparro, S.; Gómez-Huelgas, R.
De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study. J. Clin. Med. 2021, 10, 2013.
https://doi.org/10.3390/jcm10092013
AMA Style
Pérez-Belmonte LM, Ricci M, Sanz-Cánovas J, Cobos-Palacios L, López-Carmona MD, Ruiz-Moreno MI, Millán-Gómez M, Bernal-López MR, Jansen-Chaparro S, Gómez-Huelgas R.
De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study. Journal of Clinical Medicine. 2021; 10(9):2013.
https://doi.org/10.3390/jcm10092013
Chicago/Turabian Style
Pérez-Belmonte, Luis M., Michele Ricci, Jaime Sanz-Cánovas, Lidia Cobos-Palacios, María D. López-Carmona, M. Isabel Ruiz-Moreno, Mercedes Millán-Gómez, M. Rosa Bernal-López, Sergio Jansen-Chaparro, and Ricardo Gómez-Huelgas.
2021. "De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study" Journal of Clinical Medicine 10, no. 9: 2013.
https://doi.org/10.3390/jcm10092013
APA Style
Pérez-Belmonte, L. M., Ricci, M., Sanz-Cánovas, J., Cobos-Palacios, L., López-Carmona, M. D., Ruiz-Moreno, M. I., Millán-Gómez, M., Bernal-López, M. R., Jansen-Chaparro, S., & Gómez-Huelgas, R.
(2021). De-Intensification of Antidiabetic Treatment Using Canagliflozin in Patients with Heart Failure and Type 2 Diabetes: Cana-Switch-HF Study. Journal of Clinical Medicine, 10(9), 2013.
https://doi.org/10.3390/jcm10092013
